$SRRA
Sierra Oncology Inc
PRICE
$54.99 ▲0.036%
Last Close
VOLUME
594,648
DAY RANGE
54.98 - 55.17
52 WEEK
14.91 - 55.19
Join Discuss about SRRA with like-minded investors
@maletone #StockTraders.NET
took some small $SRRA short but will cover over the hod
109 Replies 11 👍 14 🔥
@Baljit123 #StockTraders.NET
SRRA - This is a COMPLETE avoid for me unless it goes RED for a NAIL AND BAIL ONLY due to ETB and it trapping everyday. This is NOT setup I love TSLA - Looking to go long on a r/g reclaim VXX - Looking to short if the markets hold GREEN today
46 Replies 13 👍 6 🔥
Key Metrics
Market Cap
0
Beta
0
Avg. Volume
404.77 K
Shares Outstanding
24.42 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
Sierra Oncology is a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer. Sierra Oncology harnesses its deep scientific expertise to identify compounds that target the root cause of disease to advance targeted therapies with assets on the leading edge of cancer biology. Its team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.
CEO: Stephen Dilly
Website: www.sierraoncology.com
HQ: 2150 ? 885 West Georgia Street Vancouver, V6C 3E8 British Columbia
Related News